CB2 Insights Inc News - CBII

CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK

Company strengthens market presence in United Kingdom with licensing of Electronic Data Capture Technology in...

CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus

Company recruits prominent Colombian naturopathic and integrative medicine physician Dr. Paola Cubillos, MD, ND...

CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions

TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“CB2” or the “Company”), a...

CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019

TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or the “Company”) (CSE:CBII; OTCQB:CBIIF), a...

CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive

TORONTO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Adds Former Johnson & Johnson Executive as Director

TORONTO, July 31, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot

NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest...

CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations

TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIT) (“CB2” or the “Company”), a...

CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics

TORONTO, June 25, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CB2 Insights Inc (CBII)

Professional-Grade Tools, for Individual Investors.

CBII News

CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK

CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus

CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions

CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019

CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive

CB2 Insights Adds Former Johnson & Johnson Executive as Director

CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot

CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations

CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics

CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update

CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019

CB2 Insights to Host Q12019 Earnings Call on May 31, 2019

CB2 Insights Completes Acquisition of Cannabis Evaluation Clinics in Arizona and Colorado

CB2 Insights Acquires Multi-Location Medical Cannabis Clinic Group, Relaxed Clarity

REPEAT - Premier Health Signs Agreement with CB2 Insights to Integrate Medical Cannabis Clinical Decision Support Tool

CBII Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CB2 Insights Inc (CBII) News

CB2 Insights Inc (CBII)

Professional-Grade Tools, for Individual Investors.

CBII News

CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK

CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus

CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions

CB2 Insights to Host Q2 2019 Earnings Call on August 28, 2019

CB2 Insights Announces New Appointment to Board of Directors with Medical Cannabis and Capital Markets Executive

CB2 Insights Adds Former Johnson & Johnson Executive as Director

CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot

CB2 Insights and Premier Health Group Move to Second Phase of Primary Care Physician Tools for Medical Cannabis Evaluations

CB2 Insights Expands Clinical Division into New Jersey with the Asset Acquisition of New Jersey Alternative Medicine Clinics

CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update

CB2 Insights Posts Strong Growth in Clinical Revenue and Drives Operating Efficiencies in Q1 2019

CB2 Insights to Host Q12019 Earnings Call on May 31, 2019

CB2 Insights Completes Acquisition of Cannabis Evaluation Clinics in Arizona and Colorado

CB2 Insights Acquires Multi-Location Medical Cannabis Clinic Group, Relaxed Clarity

REPEAT - Premier Health Signs Agreement with CB2 Insights to Integrate Medical Cannabis Clinical Decision Support Tool

CBII Discussion

Your Recent History